Literature DB >> 27137744

Changes for clozapine monitoring in the United States.

T Bastiampillai1,2,3, A Gupta4, S K W Chan5,6, S Allison7.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27137744     DOI： 10.1038/mp.2016.66

Source DB:  PubMed          Journal:  Mol Psychiatry        ISSN： 1359-4184            Impact factor:   15.992


× No keyword cloud information.
  13 in total

1.  Granulocyte colony-stimulating factor for clozapine-induced agranulocytosis.

Authors:  S L Gerson; G Gullion; H S Yeh; C Masor
Journal:  Lancet       Date:  1992-10-31       Impact factor: 79.321

2.  Clozapine, agranulocytosis, and benign ethnic neutropenia.

Authors:  S Rajagopal
Journal:  Postgrad Med J       Date:  2005-09       Impact factor: 2.401

3.  Effects of the clozapine national registry system on incidence of deaths related to agranulocytosis.

Authors:  G Honigfeld
Journal:  Psychiatr Serv       Date:  1996-01       Impact factor: 3.084

4.  Letter: Clozapine and agranulocytosis.

Authors:  J Idänpään-Heikkilä; E Alhava; M Olkinuora; I Palva
Journal:  Lancet       Date:  1975-09-27       Impact factor: 79.321

5.  Long-term combination treatment with clozapine and filgrastim in patients with clozapine-induced agranulocytosis.

Authors:  Staffan Hägg; Staffan Rosenius; Olav Spigset
Journal:  Int Clin Psychopharmacol       Date:  2003-05       Impact factor: 1.659

6.  Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine.

Authors:  J Kane; G Honigfeld; J Singer; H Meltzer
Journal:  Arch Gen Psychiatry       Date:  1988-09

7.  Successful Use of Single Doses of Granulocyte-Colony Stimulating Factor (G-CSF) in the Treatment of Late-Onset Agranulocytosis Associated With Clozapine in a Patient With Treatment-Resistant Schizophrenia: A Case Report.

Authors:  Carla Comacchio; Nicola Dusi; Antonio Lasalvia
Journal:  J Clin Psychopharmacol       Date:  2016-04       Impact factor: 3.153

8.  Mechanism of clozapine-induced agranulocytosis : current status of research and implications for drug development.

Authors:  M Pirmohamed; K Park
Journal:  CNS Drugs       Date:  1997-02       Impact factor: 5.749

Review 9.  Haematological toxicity of drugs used in psychiatry.

Authors:  Robert J Flanagan; Louisa Dunk
Journal:  Hum Psychopharmacol       Date:  2008-01       Impact factor: 1.672

10.  Add-on filgrastim during clozapine rechallenge unsuccessful in preventing agranulocytosis.

Authors:  Andreia W P Hazewinkel; Jan P A M Bogers; Erik J Giltay
Journal:  Gen Hosp Psychiatry       Date:  2013-02-06       Impact factor: 3.238
View more
  2 in total

1.  There Is Life After the UK Clozapine Central Non-Rechallenge Database.

Authors:  Ebenezer Oloyede; Cecilia Casetta; Olubanke Dzahini; Aviv Segev; Fiona Gaughran; Sukhi Shergill; Alek Mijovic; Marinka Helthuis; Eromona Whiskey; James Hunter MacCabe; David Taylor
Journal:  Schizophr Bull       Date:  2021-07-08       Impact factor: 9.306

2.  Clozapine re-challenge and initiation following neutropenia: a review and case series of 14 patients in a high-secure forensic hospital.

Authors:  Edward Silva; Melanie Higgins; Barbara Hammer; Paul Stephenson
Journal:  Ther Adv Psychopharmacol       Date:  2021-06-21
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.